These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2019454)

  • 21. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Moncrieff MD; Gyorki D; Saw R; Spillane AJ; Thompson JF; Peach H; Oudit D; Geh J; Dziewulski P; Wilson E; Matteucci P; Pritchard-Jones R; Olofsson Bagge R; Wright FC; Crampton N; Cassell O; Jallali N; Berger A; Kelly J; Hamilton S; Durrani A; Lo S; Paton E; Henderson MA
    Ann Surg Oncol; 2018 Sep; 25(9):2541-2549. PubMed ID: 29850955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous melanomas seen as inflamed pigmented lesions in patients undergoing adjuvant interferon treatment: a possible diagnostic clue for physicians.
    Hu S; Kim CC; Jessup C; Phung TL; Curiel-Lewandrowski C
    Arch Dermatol; 2009 May; 145(5):565-8. PubMed ID: 19451501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters.
    Kumar S; Holmgren A
    Carcinogenesis; 1999 Sep; 20(9):1761-7. PubMed ID: 10469622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumption of the epidermis in acral lentiginous melanoma.
    Ohata C; Nakai C; Kasugai T; Katayama I
    J Cutan Pathol; 2012 Jun; 39(6):577-81. PubMed ID: 22574622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma.
    Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT
    Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine.
    Schallreuter KU; Wood JM
    Biochim Biophys Acta; 1991 Jun; 1096(4):277-83. PubMed ID: 2065101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EF-hands calcium binding regulates the thioredoxin reductase/thioredoxin electron transfer in human keratinocytes.
    Schallreuter KU; Pittelkow MR; Wood JM
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1311-6. PubMed ID: 2475107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hermansky-Pudlak syndrome in a Swiss population.
    Schallreuter KU; Frenk E; Wolfe LS; Witkop CJ; Wood JM
    Dermatology; 1993; 187(4):248-56. PubMed ID: 8274781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
    Redondo P; Lloret P; Idoate M; Inoges S
    Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
    Starz H; Balda BR
    Int J Cancer; 2007 Aug; 121(3):689-93. PubMed ID: 17397029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of thioredoxin reductase 1 in melanoma metabolism and metastasis.
    Cassidy PB; Honeggar M; Poerschke RL; White K; Florell SR; Andtbacka RH; Tross J; Anderson M; Leachman SA; Moos PJ
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):685-95. PubMed ID: 26184858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
    Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
    Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.
    Böni R; Bantschapp O; Müller B; Burg G
    Dermatology; 1998; 196(3):288-91. PubMed ID: 9621133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival.
    Rubel F; Kern JS; Technau-Hafsi K; Uhrich S; Thoma K; Häcker G; von Bubnoff N; Meiss F; von Bubnoff D
    J Invest Dermatol; 2018 Mar; 138(3):679-687. PubMed ID: 29054599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in thin cutaneous malignant melanoma.
    Månsson-Brahme E; Carstensen J; Erhardt K; Lagerlöf B; Ringborg U; Rutqvist LE
    Cancer; 1994 May; 73(9):2324-32. PubMed ID: 8168037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
    Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
    Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.